12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Iterum Therapeutics (NASDAQ:ITRM) shares moved upwards by 8.5% to $1.28 during Friday’s after-market session. The company’s market…
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Akanda (NASDAQ:AKAN) stock increased by 31.3% to $0.21 during Friday’s pre-market session. The market value of their…
Synlogic’s Experimental Drug Lowers Urinary Oxalate In Gastric Bypass Patients
Synlogic Inc's (NASDAQ: SYBX) SYNB8802 has demonstrated proof of concept through a clinically significant lowering of urinary oxalate in a Phase 1b study in patients with a history of gastric bypass surgery.
Synlogic Announces SYNB1353 Achieves Proof Of Mechanism For Treatment Of Homocystinuria
Synlogic, Inc. (NASDAQ:SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, today announced that SYNB1353 has
‘Synlogic Gets FDA Orphan Drug Designation For Live Biotherapeutic For Treatment Of Homocystinuria’ – FDA
Search Orphan Drug Designations and Approvals (fda.gov)
Chardan Capital Maintains Buy on Synlogic, Lowers Price Target to $7
Chardan Capital analyst Keay Nakae maintains Synlogic (NASDAQ:SYBX) with a Buy and lowers the price target from $9 to $7.
Synlogic Touts Positive Data From Rare Inherited Disorder Trial, Pivotal Study To Start Next Year
Synlogic Inc (NASDAQ:SYBX) announced topline data from the Phase 2 Synpheny-1 study in phenylketonuria (PKU), a rare inherited disorder that causes…